GH Research (GHRS) Net Cash Flow (2020 - 2025)
GH Research's (GHRS) quarterly Net Cash Flow came in at -$3.6 million in Q4 2025, down 132.87% year-on-year from $10.8 million in Q4 2024, and up 10.24% quarter-over-quarter from -$4.0 million in Q3 2025.
GH Research (GHRS) Net Cash Flow (2020 - 2025) Analysis & Trends
GH Research's Net Cash Flow history runs 6 years deep, the most recent figure standing at -$3.6 million for Q4 2025.
- On a quarterly basis, Net Cash Flow fell 132.87% year-over-year to -$3.6 million in Q4 2025; TTM through Dec 2025 was $142.3 million, a 531.03% increase from a year earlier, with the FY2025 full-year figure at $142.3 million, up 531.03% from the prior year.
- Net Cash Flow grew to -$3.6 million in Q4 2025 per GHRS's latest filing, from -$4.0 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $195.1 million in Q4 2022 and bottomed at -$61.0 million in Q1 2023.
- The 5-year median for Net Cash Flow is -$3.7 million (2021), against an average of $11.7 million.
- Across the five-year window, Net Cash Flow tumbled 15309.09% in 2021 and soared 16496.25% in 2025, its largest moves.
- Year by year, Net Cash Flow stood at -$3.9 million in 2021, then soared by 5053.34% to $195.1 million in 2022, then sank by 106.02% to -$11.7 million in 2023, then jumped by 192.18% to $10.8 million in 2024, then plunged by 132.87% to -$3.6 million in 2025.
- Per Business Quant, the three latest GHRS Net Cash Flow figures stand at -$3.6 million (Q4 2025), -$4.0 million (Q3 2025), and $5.7 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | GH Research | 1.69 Bn | 1.69 Bn | - | -3.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.56 Mn |
| Dec 31, 2025 | -3.56 Mn |
| Sep 30, 2025 | -3.96 Mn |
| Sep 30, 2025 | -3.96 Mn |
| Jun 30, 2025 | 5.67 Mn |
| Jun 30, 2025 | 5.67 Mn |
| Mar 31, 2025 | 144.12 Mn |
| Mar 31, 2025 | 144.12 Mn |
| Dec 31, 2024 | 10.83 Mn |
| Dec 31, 2024 | 10.83 Mn |
| Sep 30, 2024 | 2.92 Mn |
| Sep 30, 2024 | 2.92 Mn |
| Jun 30, 2024 | 9.68 Mn |
| Jun 30, 2024 | 9.68 Mn |
| Mar 31, 2024 | -879,000.00 |
| Mar 31, 2024 | -879,000.00 |
| Dec 31, 2023 | -11.74 Mn |
| Dec 31, 2023 | -11.74 Mn |
| Sep 30, 2023 | -10.35 Mn |
| Sep 30, 2023 | -10.35 Mn |